This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Robert T. Brodell, MD

Arch Dermatol. 1996;132(9):1013-1015.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The ethical foundation on which my medical practice is based was recently shaken by an episode involving the intrusion of managed care into my practice. With the patient's informed consent, I prescribed a medication that I knew would not work.

REPORT OF A CASE

A 46-year-old man presented for evaluation of his thickened, dystrophic toenails, which had caused him pain whenever he jogged. Physical examination revealed dry, moccasin-type scaling of his feet and yellowing, subungual hyperkeratosis, dystrophy, and distal onycholysis involving all 10 toenails.

A potassium hydroxide preparation was obtained from the subungual debris, which showed septate hyphae, confirming the diagnosis of tinea pedis and onychomycosis. A prescription for oral itraconazole (200 mg twice a day for 1 week) was written, with 1 refill, and the patient was instructed to take the medication for 1 week each month following a pulse therapy protocol. Risks and benefits were discussed.

Two hours . . . [Full Text PDF of this Article]

Author Affiliations
From the Department of Internal Medicine, Dermatology Section, Northeastern Ohio Universities College of Medicine, Rootstown, and the Department of Dermatology, Case Western Reserve University School of Medicine, Cleveland, Ohio.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?